Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

ClinicalTrials.gov ID: NCT06308614

Public ClinicalTrials.gov record NCT06308614. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:06 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo-controlled Proof-of-Concept Study to Evaluate the Efficacy and Safety of Estetrol in Postmenopausal Subjects With Female Sexual Arousal Disorder

Study identification

NCT ID
NCT06308614
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Estetra
Industry
Enrollment
82 participants

Conditions and interventions

Interventions

  • Estetrol Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
40 Years to 65 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 28, 2024
Primary completion
Mar 13, 2025
Completion
Apr 20, 2025
Last update posted
Jul 5, 2026

2024 – 2025

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
23
Facility City State ZIP Site status
Estetra Study Site Mesa Arizona 85209
Estetra Study Site Phoenix Arizona 85032
Estetra Study Site Tucson Arizona 85715
Estetra Study Site Pomona California 91767
Estetra Study Site San Diego California 92111
Estetra Study Site Jacksonville Florida 32256
Estetra Study Site Miami Florida 33173
Estetra Study Site New Port Richey Florida 34562
Estetra Study Site Ocoee Florida 34761
Estetra Study Site Orlando Florida 32801
Estetra Study Site West Palm Beach Florida 33409
Estetra Study Site Atlanta Georgia 30328
Estetra Study Site Chicago Illinois 60643
Estetra Study Site Omaha Nebraska 68114
Estetra Study Site Las Vegas Nevada 89109
Estetra Study Site Albuquerque New Mexico 87102
Estetra Study Site Cleveland Ohio 44106
Estetra Study Site Englewood Ohio 45322
Estetra Study Site Memphis Tennessee 38119
Estetra Study Site Houston Texas 77061
Estetra Study Site Houston Texas 77074
Estetra Study Site Salt Lake City Utah 84107
Estetra Study Site Virginia Beach Virginia 23456
Estetra Study Site Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06308614, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06308614 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →